Statistics on Biotechnology Use  
Results by fields of operation
Total sectors. Biotechnology results by main variables and fields of operation. 
Unidades: 

,Total 2020,Companies,P.A.,Higher Education,PNPI,
Companies that perform R+D in Biotechnology,1.430,1.233,118,67,12,
%Companies according to biotechnology used: Genetic code,39,1,31,7,89,86,6,41,7,
%Companies according to biotechnology used: Functional Companies,45,2,38,5,88,1,91,58,3,
%Companies according to biotechnology used: Cellular and tissue culturing and engineering,30,1,22,8,73,7,80,6,75,
%Companies according to biotechnology used: Bioprocesses,55,7,53,4,57,6,94,58,3,
%Companies according to biotechnology used: Sub-cellular organisms,15,8,8,6,55,9,74,6,33,3,
%Companies according to biotechnology used: Bio-computing,29,2,22,3,71,2,85,1,16,7,
%Companies according to biotechnology used: Nanobiotechnology,16,6,10,6,50,68,7,8,3,
%Companies according to biotechnology used: Other,12,7,14,2,1,7,7,5,0,
Companies in which biotechnology activities are:  Main and/or exclusive,653,615,29,2,7,
Companies in which biotechnology activities are: A secondary line of business,262,178,35,48,1,
Companies in which biotechnology activities are: A tool necessary for production,515,440,54,17,4,
%Companies by field(s) of ultimate application of biotechnology use: Human health,51,46,77,91,67,
%Companies by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture,19,16,19,70,25,
%Companies by field(s) of ultimate application of biotechnology use: Food products,33,32,23,79,0,
%Companies by field(s) of ultimate application of biotechnology use: Agriculture and forest production:,27,25,23,73,33,
%Companies by field(s) of ultimate application of biotechnology use: Environment,19,16,23,76,8,
%Companies by field(s) of ultimate application of biotechnology use: Industry,16,13,14,70,8,
Personnel in R&D in biotechnology (no. of persons),43.568,13.444,14.558,15.422,144,
Personnel in R&D in biotechnology (no. of persons): Researchers,28.824,7.378,8.979,12.379,88,
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants,14.744,6.066,5.579,3.043,56,
Personnel in R&D in biotechnology (no. of persons): women,24.402,7.501,9.115,7.689,97,
Personnel in R&D in biotechnology (no. of persons): (women) Researchers,15.288,4.052,5.262,5.916,58,
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants,9.115,3.450,3.853,1.773,39,
Personnel in R&D in biotechnology (FTE),30.003,8,9.401,9,10.846,1,9.663,9,91,9,
Personnel in R&D in biotechnology (FTE): Researchers,19.421,7,5.398,3,6.270,9,7.692,1,60,4,
Personnel in R&D in biotechnology (FTE): Technicians and assistants,10.582,1,4.003,6,4.575,2,1.971,8,31,5,
Personnel in R&D in biotechnology (FTE): women,17.268,4,5.426,2,6.853,1,4.923,3,65,8,
Personnel in R&D in biotechnology (FTE): (women) Researchers,10.512,7,3.016,4,3.680,8,3.774,1,41,4,
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants,6.755,7,2.409,8,3.172,3,1.149,2,24,4,
Internal expenditure on R&D (thousands of euros),2.059.394,897.333,678.685,477.628,5.748,
1) By nature of the expense: Current expenses,1.896.836,817.409,632.188,441.712,5.526,
1.1) Remuneration to researchers,815.653,295.705,238.938,279.152,1.859,
1.2) Remuneration to technicians and assistants,346.532,156.853,127.778,61.050,851,
1.3) Other current expenses,734.651,364.852,265.472,101.510,2.817,
2) By nature of the expense: Capital expenses,162.558,79.924,46.497,35.916,221,
2.1) Land and buildings,21.618,10.272,4.863,6.483,0,
2.2) Equipment and instruments,125.071,56.609,40.467,27.780,216,
2.3) Acquisition of specific R+D software,7.349,4.839,969,1.541,1,
2.4) Otros productos de propiedad intelectual específicos para I+D,8.519,8.203,199,112,5,
1.1) By origin of the funds: Own funds,772.786,613.097,68.653,88.724,2.311,
1.2) By origin of the funds: From companies,222.014,86.085,110.014,25.119,796,
1.3) By origin of the funds: Public Administration funds,824.067,92.140,416.365,314.573,989,
1.4) By origin of the funds: From Universities,6.337,853,1.238,4.246,0,
1.5) By origin of the funds: From non profit private institutions,29.754,4.682,15.618,8.422,1.032,
1.6) By origin of the funds: Foreign funds,204.436,100.476,66.798,36.544,619,
Purchase of services R & D in Biotechnology to (thousands of euros),114.577,85.011,21.442,7.429,695,
Purchase of services R & D in Biotechnology to (thousands of euros): in Spain,81.403,54.243,19.374,7.134,652,
Purchase of services R & D in Biotechnology to (thousands of euros): Abroad,33.174,30.768,2.068,294,43,
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital,42,2,39,2,61,58,2,75,
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information,10,9,11,7,3,4,10,4,8,3,
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources,16,2,12,5,41,5,38,8,25,
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain,13,6,10,9,29,7,34,3,16,7,
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets,17,1,14,3,31,4,41,8,25,
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of distribution and marketing channels,19,17,29,40,25,
%Companies that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception,14,5,15,9,3,10,4,33,3,
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements,36,36,37,34,58,
%Companies that consider the following obstacles as very important considering biotechnology development: Time / cost,48,6,46,7,60,2,59,7,66,7,
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting,19,19,21,2,13,4,25,
%Companies that have requested biotechnology patents in Biotechnology,22,9,17,3,53,4,73,1,8,3,
Number of patents requested,1.991,681,698,611,1,
Notas:
'..'=data not available 

 '.'=numeric piece of data equal to zero not resulting from rounding 

 FTE: Full Time Equivalent 

 (*) Total calculated from the total number of companies with related activities  with Biotechnology and the total Companies from other sectors with activities  in R&D in Biotechnology
Fuente: National Statistics Institute